https://www.selleckchem.com/products/rgt-018.html
an 16.9 hours; IQR 11.9-34.5 hours) (adjusted hazard ratio [aHR] = 1.68; 95% CI, 1.18-2.38; P = .004). Cumulative incidence analysis also revealed shorter time to insulin infusion discontinuation in the balanced crystalloids group (median 9.8 hours; IQR 5.1-17.0 hours) than the saline group (median 13.4 hours; IQR 11.0-17.9 hours) (aHR = 1.45; 95% CI, 1.03-2.03; P = .03). In this secondary analysis of 2 cluster randomized clinical trials, compared with saline, treatment with balanced crystalloids resulted in more rapid resolution of DKA
Like
Comment
Share
